SIRITHEPPHAVANH OLIVER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care SEATTLE, WA NPI 1013299197
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care WA GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$17,629.49
- Category: General Payments
- Program years: PY2021–2024
- Record count: 41
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $590.68 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $590.68 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $141.09 | 2 |
| PFIZER INC. | $125.00 | 1 |
| Janssen Biotech, Inc. | $124.99 | 1 |
| Genmab U.S., Inc. | $124.93 | 1 |
| Agios Pharmaceuticals, Inc. | $74.67 | 1 |
By program year
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078829527 | Janssen Biotech, Inc. | $124.99 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116419032 | GlaxoSmithKline, LLC. | $16.10 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116526424 | GlaxoSmithKline, LLC. | $124.99 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126839132 | Genmab U.S., Inc. | $124.93 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131468000 | PFIZER INC. | $125.00 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149642476 | Agios Pharmaceuticals, Inc. | $74.67 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.